Prelude Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Prelude Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,700	Closed	-$747K	–	2419
2019 Q3	$747K	Buy	7,700 +600	+8%	+$60.1K	0.03%	423
2019 Q2	$727K	Buy	+7,100	New	+$766K	0.04%	423

Prelude Capital Management's ONCE Position: Q4 2019 in Review

Prelude Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 239,791 shares — an estimated $23.3M sold.

Prelude Capital Management first reported a position in ONCE in Q2 2015 and held it in 8 quarters. The position peaked at $24M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Prelude Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Prelude Capital Management sold 239,791 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $23.3M.
Prelude Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
Prelude Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $24M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.